Related references
Note: Only part of the references are listed.Epigenetic Silencing of Tumor Suppressor lncRNA NKILA: Implication on NF-?B Signaling in Non-Hodgkin's Lymphoma
Min-Yue Zhang et al.
GENES (2022)
Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis
Yago Nieto et al.
HAEMATOLOGICA (2022)
Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma
Matias Autio et al.
HAEMATOLOGICA (2021)
Higher infiltration of intratumoral CD25+FOXP3+lymphocytes correlates with a favorable prognosis in patients with diffuse large B-cell lymphoma
Chen Chang et al.
LEUKEMIA & LYMPHOMA (2021)
Rituximab plus gemcitabine and oxaliplatin (R-GemOx) in refractory/relapsed diffuse large B-cell lymphoma: a real-life study in patients ineligible for autologous stem-cell transplantation
Clarisse Cazelles et al.
LEUKEMIA & LYMPHOMA (2021)
High levels of Tim-3+Foxp3+Treg cells in the tumor microenvironment is a prognostic indicator of poor survival of diffuse large B cell lymphoma patients
Weijie Zhong et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Increased Blood Monocytic Myeloid Derived Suppressor Cells but Low Regulatory T Lymphocytes in Patients with Mild COVID-19
Carlos Jimenez-Cortegana et al.
VIRAL IMMUNOLOGY (2021)
Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer
Natalia Palazon-Carrion et al.
SCIENTIFIC REPORTS (2021)
Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial
Carlos Jimenez-Cortegana et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis
Yao-Hui Huang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study
Simone Ferrero et al.
HAEMATOLOGICA (2020)
Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Laurie H. Sehn et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Immunotherapy of lymphomas
Stephen M. Ansell et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
AID assists DNMT1 to attenuate BCL6 expression through DNA methylation in diffuse large B-cell lymphoma cell lines
Junna Jiao et al.
NEOPLASIA (2020)
Targeting Nuclear LSD1 to Reprogram Cancer Cells and Reinvigorate Exhausted T Cells via a Novel LSD1-EOMES Switch
Wen Juan Tu et al.
FRONTIERS IN IMMUNOLOGY (2020)
Plasma circulating tumor DNA assessment reveals KMT2D as a potential poor prognostic factor in extranodal NK/T-cell lymphoma
Qiong Li et al.
BIOMARKER RESEARCH (2020)
Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study
Gilles Salles et al.
LANCET ONCOLOGY (2020)
Tumor-associated macrophages in classical Hodgkin lymphoma: hormetic relationship to outcome
Laura Werner et al.
SCIENTIFIC REPORTS (2020)
Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials
Lourdes Hontecillas-Prieto et al.
FRONTIERS IN GENETICS (2020)
Activating the Antitumor Immune Response in Non-Hodgkin Lymphoma Using Immune Checkpoint Inhibitors
Maansi Joshi et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
Tumor-Associated Macrophages in Tumor Immunity
Yueyun Pan et al.
FRONTIERS IN IMMUNOLOGY (2020)
Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma in Asia Frequently Shows SETD2 Alterations
Sakura Tomita et al.
CANCERS (2020)
Heterogeneity of Regulatory T Cells in B-Cell Non-Hodgkin Lymphoma
Ivana Spasevska et al.
BLOOD (2020)
Role of Circulating Myeloid-Derived Suppressor Cell (MDSC) in Hodgkin Lymphoma (HL) Progression: Updated Prospective Study
Olga Novosad et al.
BLOOD (2020)
A Survey of Somatic Mutations in 41 Genes in a Cohort of T-Cell Lymphomas Identifies Frequent Mutations in Genes Involved in Epigenetic Modification
Sebastian Fernandez-Pol et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2019)
Aberrant differential expression of EZH2 and H3K27me3 in extranodal NK/T-cell lymphoma, nasal type, is associated with disease progression and prognosis
Jumei Liu et al.
HUMAN PATHOLOGY (2019)
Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade
Ye Qin et al.
ONCOGENE (2019)
Modulation of immune checkpoint molecule expression in mantle cell lymphoma
Bonnie K. Harrington et al.
LEUKEMIA & LYMPHOMA (2019)
MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells
Zhong Zheng et al.
MOLECULAR CANCER (2019)
Clinical significance of enhancer of zeste homolog 2 and histone deacetylases 1 and 2 expression in peripheral T-cell lymphoma
Huilai Zhang et al.
ONCOLOGY LETTERS (2019)
Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer
Peiwen Ma et al.
FRONTIERS IN IMMUNOLOGY (2019)
Targeting the Immune Microenvironment in Lymphomas of B-Cell Origin: From Biology to Clinical Application
Tom A. Mulder et al.
CANCERS (2019)
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087
Robert Chen et al.
BLOOD (2019)
Lymphomas and Their Microenvironment: A Multifaceted Relationship
Thomas Menter et al.
PATHOBIOLOGY (2019)
A circular RNA from APC inhibits the proliferation of diffuse large B-cell lymphoma by inactivating Wnt/β-catenin signaling via interacting with TET1 and miR-888
Yanping Hu et al.
AGING-US (2019)
The Acidic Tumor Microenvironment as a Driver of Cancer
Ebbe Boedtkjer et al.
Annual Review of Physiology (2019)
Immune and Inflammatory Cells of the Tumor Microenvironment Represent Novel Therapeutic Targets in Classical Hodgkin Lymphoma
Eleonora Calabretta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Tumor-Infiltrating Immunosuppressive Cells in Cancer-Cell Plasticity, Tumor Progression and Therapy Response
Laura Lorenzo-Sanz et al.
CANCER MICROENVIRONMENT (2019)
Downregulation of miR-152 contributes to DNMT1-mediated silencing of SOCS3/SHP-1 in non-Hodgkin lymphoma
Qing-Ming Wang et al.
CANCER GENE THERAPY (2019)
CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
Bagher Farhood et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Stephen J. Schuster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
If we build it they will come: targeting the immune response to breast cancer
Margaret E. Gatti-Mays et al.
NPJ BREAST CANCER (2019)
Distinct epigenetic features of tumor-reactive CD8+T cells in colorectal cancer patients revealed by genome-wide DNA methylation analysis
Rui Yang et al.
GENOME BIOLOGY (2019)
The Phagocytic Function of Macrophage-Enforcing Innate Immunity and Tissue Homeostasis
Daisuke Hirayama et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Activation of RHOA-VAV1 signaling in angioimmunoblastic T-cell lymphoma
M. Fujisawa et al.
LEUKEMIA (2018)
A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806
Daniel O. Persky et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified
Meng-Meng Ji et al.
HAEMATOLOGICA (2018)
Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial
Philippe Armand et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma
J. M. Connors et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
DNMT1 is associated with cell cycle and DNA replication gene sets in diffuse large B-cell lymphoma
Suet Kee Loo et al.
PATHOLOGY RESEARCH AND PRACTICE (2018)
Epigenetic regulators of programmed death-ligand 1 expression in human cancers
Sachin Kumar et al.
TRANSLATIONAL RESEARCH (2018)
Prognostic significance of CD68, CD163 and Folate receptorβ positive macrophages in hepatocellular carcinoma
Koji Minami et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
The bitter side of epigenetics: variability and resistance to chemotherapy
Nabil Hajji et al.
Epigenomics (2018)
Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity
David Wang et al.
CELL REPORTS (2018)
Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified
Meng-Meng Ji et al.
HAEMATOLOGICA (2018)
Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy
Aurelie Durgeau et al.
FRONTIERS IN IMMUNOLOGY (2018)
Mechanisms of immune evasion and immune Modulation by Lymphoma Cells
Thomas Menter et al.
FRONTIERS IN ONCOLOGY (2018)
Enzyme-free digital counting of endogenous circular RNA molecules in B-cell malignancies
Mette Dahl et al.
LABORATORY INVESTIGATION (2018)
Review of the biologic and clinical significance of genetic mutations in angioimmunoblastic T-cell lymphoma
Kota Fukumoto et al.
CANCER SCIENCE (2018)
Loss of HDAC11 Promotes Myeloid-Derived Suppressor Cells Inhibition of T Cell Function in a Murine Lymphoma Microenvironment
Jie Chen et al.
BLOOD (2018)
PD-1 expression and clinical PD-1 blockade in B-cell lymphomas
Zijun Y. Xu-Monette et al.
BLOOD (2018)
High myeloid-derived suppressor cell frequencies in the duodenum are associated with enteropathy associated T-cell lymphoma and its precursor lesions
Hetty J. Bontkes et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Histone deacetylase inhibitors interrupt HSP90•RASGRP1 and HSP90•CRAF interactions to upregulate BIM and circumvent drug resistance in lymphoma cells
H. Ding et al.
LEUKEMIA (2017)
PD-1-PD-L1 immune-checkpoint blockade in B-cell lymphomas
Aaron Goodman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Lymphocyte-to-monocyte ratio is associated with prognosis of diffuse large B-cell lymphoma: correlation with CD163 positive M2 type tumor-associated macrophages, not PD-1 positive tumor-infiltrating lymphocytes
Jingxuan Wang et al.
ONCOTARGET (2017)
Circulating CXCR5+CD4+T cells assist in the survival and growth of primary diffuse large B cell lymphoma cells through interleukin 10 pathway
Zhanshan Cha et al.
EXPERIMENTAL CELL RESEARCH (2017)
Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission
Daniel J. Landsburg et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma
Robert Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2
Andrea B. Moffitt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Effects of microRNA-21 on apoptosis by regulating the expression of PTEN in diffuse large B-cell lymphoma
Jia Song et al.
MEDICINE (2017)
Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma
Meng Zhou et al.
MOLECULAR CANCER (2017)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
DNMT3B overexpression contributes to aberrant DNA methylation and MYC-driven tumor maintenance in T-ALL and Burkitt's lymphoma
Candace J. Poole et al.
ONCOTARGET (2017)
Myeloid-Derived Suppressor Cells
Dmitry I. Gabrilovich
CANCER IMMUNOLOGY RESEARCH (2017)
Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma
Christopher D. Carey et al.
BLOOD (2017)
Entinostat Neutralizes Myeloid-Derived Suppressor Cells and Enhances the Antitumor Effect of PD-1 Inhibition in Murine Models of Lung and Renal Cell Carcinoma
Ashley Orillion et al.
CLINICAL CANCER RESEARCH (2017)
Th17 immune microenvironment in Epstein-Barr virus-negative Hodgkin lymphoma: implications for immunotherapy
Amy S. Duffield et al.
BLOOD ADVANCES (2017)
The role of T cells in the microenvironment of Hodgkin lymphoma
Frederik Wein et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells
Imane Azzaoui et al.
BLOOD (2016)
Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas
David Vallois et al.
BLOOD (2016)
Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma
Baoping Guo et al.
BMC MEDICINE (2016)
Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage
Ana C. Queiros et al.
CANCER CELL (2016)
Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma
Irina V. Tiper et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Expansion and functions of myeloid-derived suppressor cells in the tumor microenvironment
Peng Qu et al.
CANCER LETTERS (2016)
Deregulated expression of HDAC9 in B cells promotes development of lymphoproliferative disease and lymphoma in mice
Veronica S. Gil et al.
DISEASE MODELS & MECHANISMS (2016)
A pilot study of long noncoding RNA expression profiling by microarray in follicular lymphoma
Yi Pan et al.
GENE (2016)
Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi
Francesco Merli et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
DNMT3AR882H mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice
L. Scourzic et al.
LEUKEMIA (2016)
A phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520
Soham D. Puvvada et al.
LEUKEMIA & LYMPHOMA (2016)
Differential expression of enhancer of zeste homolog 2 (EZH2) protein in small cell and aggressive B-cell non-Hodgkin lymphomas and differential regulation of EZH2 expression by p-ERK1/2 and MYC in aggressive B-cell lymphomas
Xuejun Tian et al.
MODERN PATHOLOGY (2016)
Targeting the cancer epigenome for therapy
Peter A. Jones et al.
NATURE REVIEWS GENETICS (2016)
Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma
Anjali Mishra et al.
CANCER DISCOVERY (2016)
The second European interdisciplinary Ewing sarcoma research summit - A joint effort to deconstructing the multiple layers of a complex disease
Heinrich Kovar et al.
ONCOTARGET (2016)
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients
Olivia Marini et al.
ONCOTARGET (2016)
Improving cancer immunotherapy by targeting the STATe of MDSCs
Nienke de Haas et al.
ONCOIMMUNOLOGY (2016)
Natural Killer Cells-An Epigenetic Perspective of Development and Regulation
Alexander Schenk et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Cutaneous CD8+ Cytotoxic T-Cell Lymphoma Infiltrates: Clinicopathological Correlation and Outcome of 35 Cases
Marion Wobser et al.
ONCOLOGY AND THERAPY (2016)
Outcomes After Chemotherapy Followed by Radiation for Stage IIB Hodgkin Lymphoma With Bulky Disease
Jay P. Reddy et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2015)
Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis
Marcela C. Robaina et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2015)
A phase II study of vorinostat and rituximab for treatment of newly diagnosed and relapsed/refractory indolent non-Hodgkin lymphoma
Robert Chen et al.
HAEMATOLOGICA (2015)
Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies
David W. Scott et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
IL10 receptor is a novel therapeutic target in DLBCLs
W. Beguelin et al.
LEUKEMIA (2015)
Histone deacetylase 11: A novel epigenetic regulator of myeloid derived suppressor cell expansion and function
Eva Sahakian et al.
MOLECULAR IMMUNOLOGY (2015)
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
Dongjun Peng et al.
NATURE (2015)
Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma
Lu Jiang et al.
NATURE GENETICS (2015)
The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development
Ana Ortega-Molina et al.
NATURE MEDICINE (2015)
Ezh2 regulates differentiation and function of natural killer cells through histone methyltransferase activity
Jie Yin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The Epigenetic Basis of Diffuse Large B-Cell Lymphoma
Yanwen Jiang et al.
SEMINARS IN HEMATOLOGY (2015)
Genetic alterations of DNA methylation machinery in human diseases
Tewfik Hamidi et al.
EPIGENOMICS (2015)
Romidepsin targets multiple survival signaling pathways in malignant T cells
B. C. Valdez et al.
BLOOD CANCER JOURNAL (2015)
IL-10 induces the development of immunosuppressive CD14+ HLA-DRlow/- monocytes in B-cell non-Hodgkin lymphoma
B. Xiu et al.
BLOOD CANCER JOURNAL (2015)
Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type
Seungbok Lee et al.
ONCOTARGET (2015)
Transcriptome sequencing reveals thousands of novel long non-coding RNAs in B cell lymphoma
Akanksha Verma et al.
GENOME MEDICINE (2015)
Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients
Emilia L. Lim et al.
GENOME BIOLOGY (2015)
A phase II study of vorinostat and rituximab for treatment of newly diagnosed and relapsed/refractory indolent non-Hodgkin lymphoma
Robert Chen et al.
HAEMATOLOGICA (2015)
Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma
Javeed Iqbal et al.
BLOOD (2015)
A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma
Francine Foss et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
High density of CD68+/CD163+tumour-associated macrophages (M2-TAM) at diagnosis is significantly correlated to unfavorable prognostic factors and to poor clinical outcomes in patients with diffuse large B-cell lymphoma
Francesco Marchesi et al.
HEMATOLOGICAL ONCOLOGY (2015)
Cross Talk between Histone Deacetylase 4 and STAT6 in the Transcriptional Regulation of Arginase 1 during Mouse Dendritic Cell Differentiation
Quan Yang et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
Hijacked in cancer: the KMT2 (MLL) family of methyltransferases
Rajesh C. Rao et al.
NATURE REVIEWS CANCER (2015)
DNMT3A in haematological malignancies
Liubin Yang et al.
NATURE REVIEWS CANCER (2015)
Histone Deacetylase 9 Represses Cholesterol Efflux and Alternatively Activated Macrophages in Atherosclerosis Development
Qiang Cao et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes
Nyasha Chambwe et al.
BLOOD (2014)
A multicentre phase II study of vorinostat in patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
Michinori Ogura et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
CD14+ HLA-DR low/-monocytes as indicator of disease aggressiveness in B-cell non-Hodgkin lymphoma
K. A. Khalifa et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2014)
Polycomb-Dependent H3K27me1 and H3K27me2 Regulate Active Transcription and Enhancer Fidelity
Karin J. Ferrari et al.
MOLECULAR CELL (2014)
Epigenetic Regulation of Macrophage Polarization by DNA Methyltransferase 3b
Xiaosong Yang et al.
MOLECULAR ENDOCRINOLOGY (2014)
Divergent roles of histone deacetylase 6 (HDAC6) and histone deacetylase 11 (HDAC11) on the transcriptional regulation of IL10 in antigen presenting cells
Fengdong Cheng et al.
MOLECULAR IMMUNOLOGY (2014)
An increase of M2 macrophages predicts poor prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone
Soo Jeong Nam et al.
LEUKEMIA & LYMPHOMA (2014)
SIRT2 Deficiency Modulates Macrophage Polarization and Susceptibility to Experimental Colitis
Giuseppe Lo Sasso et al.
PLOS ONE (2014)
Macrophages and Dendritic Cells as Actors in the Immune Reaction of Classical Hodgkin Lymphoma
Christiane Silke Tudor et al.
PLOS ONE (2014)
Epigenetic regulation in cancer progression
Eva Baxter et al.
CELL AND BIOSCIENCE (2014)
The tumour microenvironment in B cell lymphomas
David W. Scott et al.
NATURE REVIEWS CANCER (2014)
EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity
Junli Yan et al.
BLOOD (2013)
Phase I Study of Panobinostat plus Everolimus in Patients with Relapsed or Refractory Lymphoma
Yasuhiro Oki et al.
CLINICAL CANCER RESEARCH (2013)
DNA demethylation and histone H3K9 acetylation determine the active transcription of the NKG2D gene in human CD8+ T and NK cells
Alba Fernandez-Sanchez et al.
EPIGENETICS (2013)
DNA methylation profiling in human B cells reveals immune regulatory elements and epigenetic plasticity at Alu elements during B-cell activation
Anne Y. Lai et al.
GENOME RESEARCH (2013)
The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia
Davide Brusa et al.
HAEMATOLOGICA (2013)
Absolute monocytosis at diagnosis correlates with survival in diffuse large B-cell lymphomapossible link with monocytic myeloid-derived suppressor cells
Tamar Tadmor et al.
HEMATOLOGICAL ONCOLOGY (2013)
A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas
Tint Lwin et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Essential Role for Dnmt1 in the Prevention and Maintenance of MYC-Induced T-Cell Lymphomas
Staci L. Peters et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Rescue of Impaired NK Cell Activity in Hodgkin Lymphoma With Bispecific Antibodies In Vitro and in Patients
Katrin S. Reiners et al.
MOLECULAR THERAPY (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Cytokine Induced Phenotypic and Epigenetic Signatures Are Key to Establishing Specific Macrophage Phenotypes
Nicolai A. Kittan et al.
PLOS ONE (2013)
Epigenetic Silencing of the Proapoptotic Gene BIM in Anaplastic Large Cell Lymphoma through an MeCP2/SIN3a Deacetylating Complex
Rocco Piazza et al.
NEOPLASIA (2013)
DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications
Hsin-An Hou et al.
BLOOD (2012)
Dynamic Transformations of Genome-wide Epigenetic Marking and Transcriptional Control Establish T Cell Identity
Jingli A. Zhang et al.
CELL (2012)
Cancer epigenomics: beyond genomics
Juan Sandoval et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2012)
A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia
Camille Simon et al.
GENES & DEVELOPMENT (2012)
T Cell Receptor Stimulation-Induced Epigenetic Changes and Foxp3 Expression Are Independent and Complementary Events Required for Treg Cell Development
Naganari Ohkura et al.
IMMUNITY (2012)
The Epigenotype
C. H. Waddington
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2012)
De Novo DNA Methylation Is Required to Restrict T Helper Lineage Plasticity
Rajan M. Thomas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
MicroRNA-494 Is Required for the Accumulation and Functions of Tumor-Expanded Myeloid-Derived Suppressor Cells via Targeting of PTEN
Yang Liu et al.
JOURNAL OF IMMUNOLOGY (2012)
Regulation of STAT3 by histone deacetylase-3 in diffuse large B-cell lymphoma: implications for therapy
M. Gupta et al.
LEUKEMIA (2012)
Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells
P. Ame-Thomas et al.
LEUKEMIA (2012)
The role of CD40/CD40L and interferon regulatory factor 4 in Hodgkin lymphoma microenvironment
Donatella Aldinucci et al.
LEUKEMIA & LYMPHOMA (2012)
Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia
Panagiotis Ntziachristos et al.
NATURE MEDICINE (2012)
TET2 and DNMT3A Mutations in Human T-Cell Lymphoma
Lucile Couronne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
In Vivo Inhibition of c-MYC in Myeloid Cells Impairs Tumor-Associated Macrophage Maturation and Pro-Tumoral Activities
Oscar M. Pello et al.
PLOS ONE (2012)
Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)
Michael T. McCabe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages
Xuefen Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Immunosuppressive CD14+HLA-DRlow/- monocytes in B-cell non-Hodgkin lymphoma
Yi Lin et al.
BLOOD (2011)
MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype
Ellen Leich et al.
BLOOD (2011)
Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma
Richard L. Piekarz et al.
BLOOD (2011)
DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation
Rita Shaknovich et al.
BLOOD (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Molecular Pathogenesis of Hodgkin's Lymphoma: Increasing Evidence of the Importance of the Microenvironment
Christian Steidl et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial
Christian Recher et al.
LANCET (2011)
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
Michael Pfreundschuh et al.
LANCET ONCOLOGY (2011)
The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma
D. Lenze et al.
LEUKEMIA (2011)
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Ryan D. Morin et al.
NATURE (2011)
Cancer epigenetics reaches mainstream oncology
Manuel Rodriguez-Paredes et al.
NATURE MEDICINE (2011)
ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned
Simonetta Viviani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A decade of exploring the cancer epigenome - biological and translational implications
Stephen B. Baylin et al.
NATURE REVIEWS CANCER (2011)
Prognostic significance of CD95, P53, and BCL2 expression in extranodal non-Hodgkin's lymphoma
Anastasios Chatzitolios et al.
ANNALS OF HEMATOLOGY (2010)
The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation
Pedro Farinha et al.
BLOOD (2010)
Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylation
Kristie A. Blum et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
Takashi Watanabe et al.
CANCER SCIENCE (2010)
DNA methyltransferase DNMT3b protein overexpression as a prognostic factor in patients with diffuse large B-cell lymphomas
Khaled Amara et al.
CANCER SCIENCE (2010)
Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
Mark P. Chao et al.
CELL (2010)
Polycomb Group Proteins: Multi-Faceted Regulators of Somatic Stem Cells and Cancer
Martin Sauvageau et al.
CELL STEM CELL (2010)
Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin's lymphoma
Heiner Adams et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
B-cell receptor signaling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis
V. J. Craig et al.
LEUKEMIA (2010)
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Ryan D. Morin et al.
NATURE GENETICS (2010)
The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection
Takashi Satoh et al.
NATURE IMMUNOLOGY (2010)
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
Christian Steidl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Refined Prognostic Role of CD68-Positive Tumor Macrophages in the Context of the Cellular Micromilieu of Classical Hodgkin Lymphoma
Alexandar Tzankov et al.
PATHOBIOLOGY (2010)
Epigenetic regulation of the alternatively activated macrophage phenotype
Makoto Ishii et al.
BLOOD (2009)
B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders
Ryan A. Wilcox et al.
BLOOD (2009)
Decitabine Effect on Tumor Global DNA Methylation and Other Parameters in a Phase I Trial in Refractory Solid Tumors and Lymphomas
David J. Stewart et al.
CLINICAL CANCER RESEARCH (2009)
Histone deacetylase 1, 2, 6 and acetylated histone H4 in B- and T-cell lymphomas
Lena Marquard et al.
HISTOPATHOLOGY (2009)
Increased programmed death-1+tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival
Simone Muenst et al.
HUMAN PATHOLOGY (2009)
Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
Richard L. Piekarz et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Polycomb group proteins: navigators of lineage pathways led astray in cancer
Adrian P. Bracken et al.
NATURE REVIEWS CANCER (2009)
MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas
Anja Roehle et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma
Alexandar Tzankov et al.
HAEMATOLOGICA (2008)
Anergy in memory CD4+ T cells is induced by B cells
Sarat K. Dalai et al.
JOURNAL OF IMMUNOLOGY (2008)
MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation
E. Leucci et al.
JOURNAL OF PATHOLOGY (2008)
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas:: a randomised controlled trial (RICOVER-60)
Michael Pfreundschuh et al.
LANCET ONCOLOGY (2008)
Overview of lymphoma diagnosis and management
Matthew J. Matasar et al.
RADIOLOGIC CLINICS OF NORTH AMERICA (2008)
MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells
Valerie B. Sampson et al.
CANCER RESEARCH (2007)
MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma
Charles H. Lawrie et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Histone deacetylase inhibitors suppress natural killer cell cytolytic activity
Henry Ogbomo et al.
FEBS LETTERS (2007)
FDA approval summary: Vorinostat for treatment of advanced primary cutaneous T-cell lymphoma
Bhupinder S. Mann et al.
ONCOLOGIST (2007)
Altered sirtuin expression is associated with node-positive breast cancer
N. Ashraf et al.
BRITISH JOURNAL OF CANCER (2006)
Tumor-infiltrating cells as a prognostic factor in Hodgkin's lymphoma:: A quantitative tissue microarray study in a large retrospective cohort of 267 patients
T Alvaro-Naranjo et al.
LEUKEMIA & LYMPHOMA (2005)
DNA methylation and human disease
KD Robertson
NATURE REVIEWS GENETICS (2005)
Imbalances of chemokines, chemokine receptors and cytokines in Hodgkin lymphoma:: Classical Hodgkin lymphoma vs. Hodgkin-like ATLL
K Ohshima et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Nodal CD8 positive cytotoxic T-cell lymphoma: A distinct clinicopathological entity
HY Mukai et al.
MODERN PATHOLOGY (2002)
Expression profile of histone deacetylase 1 in gastric cancer tissues
JH Choi et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2001)
A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival
PP Lee et al.
IMMUNITY (2001)
A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model
CH Moskowitz et al.
BLOOD (2001)
The DNA methyltransferases of mammals
TH Bestor
HUMAN MOLECULAR GENETICS (2000)
CD8+ T cells in Hodgkin's disease tumor tissue are a polyclonal population with limited clonal expansion but little evidence of selection by antigen
K Willenbrock et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Proliferative response of mantle cell lymphoma cells stimulated by CD40 ligation and IL-4
R Castillo et al.
LEUKEMIA (2000)
Share Paper
